OSIRIS: A Minimum Data Set for Data Sharing and Interoperability in Oncology.
Journal
JCO clinical cancer informatics
ISSN: 2473-4276
Titre abrégé: JCO Clin Cancer Inform
Pays: United States
ID NLM: 101708809
Informations de publication
Date de publication:
03 2021
03 2021
Historique:
entrez:
15
3
2021
pubmed:
16
3
2021
medline:
1
9
2021
Statut:
ppublish
Résumé
Many institutions throughout the world have launched precision medicine initiatives in oncology, and a large amount of clinical and genomic data is being produced. Although there have been attempts at data sharing with the community, initiatives are still limited. In this context, a French task force composed of Integrated Cancer Research Sites (SIRICs), comprehensive cancer centers from the Unicancer network (one of Europe's largest cancer research organization), and university hospitals launched an initiative to improve and accelerate retrospective and prospective clinical and genomic data sharing in oncology. For 5 years, the OSIRIS group has worked on structuring data and identifying technical solutions for collecting and sharing them. The group used a multidisciplinary approach that included weekly scientific and technical meetings over several months to foster a national consensus on a minimal data set. The resulting OSIRIS set and event-based data model, which is able to capture the disease course, was built with 67 clinical and 65 omics items. The group made it compatible with the HL7 Fast Healthcare Interoperability Resources (FHIR) format to maximize interoperability. The OSIRIS set was reviewed, approved by a National Plan Strategic Committee, and freely released to the community. A proof-of-concept study was carried out to put the OSIRIS set and Common Data Model into practice using a cohort of 300 patients. Using a national and bottom-up approach, the OSIRIS group has defined a model including a minimal set of clinical and genomic data that can be used to accelerate data sharing produced in oncology. The model relies on clear and formally defined terminologies and, as such, may also benefit the larger international community.
Identifiants
pubmed: 33720747
doi: 10.1200/CCI.20.00094
pmc: PMC8140800
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
256-265Références
Sci Data. 2019 Jun 20;6(1):98
pubmed: 31222016
Am J Surg Pathol. 2016 Jul;40(7):896-908
pubmed: 27158754
JCO Clin Cancer Inform. 2018 Dec;2:1-12
pubmed: 30652540
JCO Clin Cancer Inform. 2018 Dec;2:1-7
pubmed: 30652539
Nature. 2014 Jan 23;505(7484):495-501
pubmed: 24390350
J Am Med Inform Assoc. 2012 Jan-Feb;19(1):54-60
pubmed: 22037893
Bull Cancer. 2016 Nov;103(11):949-950
pubmed: 27816168
Ann Oncol. 2014 Sep;25(9):1854-1860
pubmed: 24914041
J Am Med Inform Assoc. 2020 Nov 1;27(11):1808-1812
pubmed: 32885823
Cancer. 2018 Mar 15;124(6):1179-1187
pubmed: 29211310
Nat Rev Clin Oncol. 2012 Jul 10;9(8):479-86
pubmed: 22777058
Lancet. 2016 Dec 10;388(10062):2872
pubmed: 27979406
Am J Surg Pathol. 2014 Mar;38(3):293-304
pubmed: 24525499
JCO Clin Cancer Inform. 2018 Dec;2:1-8
pubmed: 30652543
Lancet Oncol. 2015 Oct;16(13):1324-34
pubmed: 26342236
JCO Clin Cancer Inform. 2018 Dec;2:1-14
pubmed: 30652542
J Biomed Semantics. 2017 Mar 7;8(1):11
pubmed: 28270198
Ann Oncol. 2019 May 1;30(5):757-765
pubmed: 30865223
Int J Radiat Oncol Biol Phys. 2018 Oct 1;102(2):399-406
pubmed: 30191871
Laryngoscope. 2015 Mar;125(3):615-23
pubmed: 25186315
Ann Oncol. 2017 Mar 1;28(3):590-596
pubmed: 27993804
Clin Invest Med. 2006 Dec;29(6):351-64
pubmed: 17330451